Search details
1.
Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.
Intern Med J
; 54(3): 398-403, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37493453
2.
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease.
Int J Mol Sci
; 24(4)2023 Feb 15.
Article
in English
| MEDLINE | ID: mdl-36835356
3.
Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
Int J Mol Sci
; 23(3)2022 Jan 30.
Article
in English
| MEDLINE | ID: mdl-35163551
4.
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.
Int J Mol Sci
; 23(20)2022 Oct 13.
Article
in English
| MEDLINE | ID: mdl-36293067
5.
Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data.
Am J Hematol
; 96(5): 545-551, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33606887
6.
Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations.
Int J Mol Sci
; 22(14)2021 Jul 19.
Article
in English
| MEDLINE | ID: mdl-34299318
7.
Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak.
Graefes Arch Clin Exp Ophthalmol
; 258(7): 1419-1426, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32346785
8.
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.
Int J Mol Sci
; 21(19)2020 Sep 24.
Article
in English
| MEDLINE | ID: mdl-32987733
9.
Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease.
Int J Mol Sci
; 20(12)2019 Jun 21.
Article
in English
| MEDLINE | ID: mdl-31234327
10.
Has Parkinson Disease Gone to the Dogs?
Mov Disord
; 38(2): 358, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36807622
11.
Rapid velaglucerase alfa infusion for Gaucher disease: 5-year data.
Intern Med J
; 52(9): 1645-1646, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36100564
12.
Gne depletion during zebrafish development impairs skeletal muscle structure and function.
Hum Mol Genet
; 23(13): 3349-61, 2014 Jul 01.
Article
in English
| MEDLINE | ID: mdl-24488768
13.
Survival-apoptosis associated signaling in GNE myopathy-cultured myoblasts.
J Recept Signal Transduct Res
; 35(4): 249-57, 2015.
Article
in English
| MEDLINE | ID: mdl-25510413
14.
Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease.
Am J Hematol
; 93(9): E246-E248, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29989200
15.
Glucosylsphingosine is a reliable response biomarker in Gaucher disease.
Am J Hematol
; 93(6): E140-E142, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29473199
16.
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy.
J Clin Med
; 12(6)2023 Mar 13.
Article
in English
| MEDLINE | ID: mdl-36983221
17.
Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy.
J Clin Med
; 11(21)2022 Oct 24.
Article
in English
| MEDLINE | ID: mdl-36362492
18.
Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease.
Thromb Haemost
; 122(6): 951-960, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34507369
19.
Pre Clinical Assessment of AAVrh74.MCK.GNE Viral Vector Therapeutic Potential: Robust Activity Despite Lack of Consistent Animal Model for GNE Myopathy.
J Neuromuscul Dis
; 9(1): 179-192, 2022.
Article
in English
| MEDLINE | ID: mdl-34806613
20.
Parkinson's Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers.
J Parkinsons Dis
; 11(2): 615-618, 2021.
Article
in English
| MEDLINE | ID: mdl-33612495